µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º [M zc^I&
NUO,"Bqq
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ =QO1FO
fQ?n(
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) IU;pkgBj0Y
PK|`}
z9
1. ICAM-1 PSrt/y!
h-)A?%Xt
2. interleukin 12(IL-12) ]!S)O|_D[
8-l)TTP&.
3. tumor infiltrating lymphocyte
Wcay'#K,
0e5-
\a
4. TCR/CD3 complex e&]`X HC9
zI*/u)48
5. hematopoietin receptor family t+TbCe
:Y)kKq d
6. individual idiotype(IdI) 5
/eS1NJ@
|@n{tog+-
7. integrin ch2e#Jf8
J\8l%4q3
8. colony-stimulatory factor (CSF) VRN9 yn2
>kLH6.
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© uB)6\fkTB
RU ,N_GV
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? !`S%l1[Z
)PZ}^Fa
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ jKi*3-&
,IvnNnl2
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óá£
oG_'<5Bv>
rp[oH=&
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ zSM7x
.g`*cDW^=
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) %a6]gsiv2<
OL9C#er
1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ E@}j}/%'O
gkn/E}K#
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) L$kAe1 V^m
->25$5#
3. immunoglobulin superfamily (IgSF) KI QBY!N+
_"Ke=v_5
4. selectin h
swMy
*A9{H>Vq
5. anti-idiotypic antibody (¦ÁId) #CP, \G
_89G2)U=C
6. major histocompatibility complex(MHC) i/EiUH/~
?4?jG3p
7. immunotolerance
bQQ/7KM
\ozy_s[
8. biological reponse modifier(BRM) ;=
@-j@?
Id
7
9. immune reponse gene (Ir gene) j1CD;9i)%
aJ_Eh(cF
10. reshaped antibody (or reconstituted antibody) "J:NW_U
M!DoR6
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© !VTS
$nJ4
5j01Mx
A
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ DL!s)5!M
hQxe0Pdt
2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? zO]dQ$r\Z
K'/x9.'%
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ OHvzK8
| N,nt@~
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? `8bp6}OD,
P[oB'
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ m:7bynT{
oh~Dbu=%
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? XArLL5_L
\R
t
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ nu-w
Qr
y>18)8
¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ /qze
>Cc$ P
1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? NFPkK?+
39eoL;O_
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ |(g2fByDf
'|r!yAO6
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: <(%uOo$
T^>cT"ux_
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: x7>sy,c
`8Ix&d3F
̉񧄤 ^PszZ10T
]7@Dqd-/S
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 8t; nU;E*
5=e@yIr'#
1. CD8 ?~8V;Qn
Hu.d^@V
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) 8a1{x(\z.
S8t9Ms:
k
3. immunoglobulin fold(Ig fold) 0't)fnI#
EA72%Y9F
4. cadherin (Ca-dependent cell adhesion moleculers) :-n4!z"k
S5M t?v|K
5. idiotype-anti-idiotypic antibody immune network theory 7="V7
K[Kc'6G
6. HLA class II antigen
|H49FL
,P]{*uqGiB
7. complementarity-determining region (CDR) Wit1WI;18
ygG9ht
8. perforin(or pore-forming protein ,PFP) IAQ=d4V&
UlR7_
9. high affinity IL-2 receptor Gl(,%~F9i
+=v|kd
10. artificial active immunization B _ >|Mo/
TDFv\y}yc
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 7}MWmS^8j
&x}JC/u]fd
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ08Gr
]T1"3
[si
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 a&JAF?k
%"tf`,d~3
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ 2]l*{l^ Bl
r iz({
4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ >ObpOFb%
x<" e
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ $kdfY'u
- >2ej4C
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? ;:OJQFu%4
]pb3
Fm{
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ '5IJ;4
k
YV9%^ZaN7
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ B{Rig5Sc
V&G_Bu~
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ =1D*K%
z&eJ?wb
ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ drH!?0Dpg
}rN"H4)
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© d 1z
>?5`FC
1. immunoglobulin gene rearrangement $>+-=XMVB
~"(1~7_
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) Y?> S
.B7
f!87JE=<
3. flow cytometry(FCM) R,(^fM
<1ai0]
4. carrier effect Z"P{/~HG
:x_l"y"
5. positive selection of T lymphocytes in thymus WTXTr0=
tZ(Wh
6. mouse TH1(Th1) and TH2(Th2) subsets !-: a`Vs+
X;- ,3dy
7. perforin (pore-forming protein ,PFP) ]UMwpL&rY
"~GudK &
8. ADCC(antibody-dependent cell-mediated cytotoxicity) NKd):>d%
/wmJMX
9. SH-2(src-homology region 2) n32?GRp
H~
(I
10. Ab2¦Â (internal image) bju
0l[;=
I@.qon2V
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© &%^[2^H8"
6~^+</?
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? =uD2j9!"7
lVMAab
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? LV`- eW
JG4
Tb{F=
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠXa-]+_?Q
tEb2>+R
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ 2 !{P<
qD2<-E&M/
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ%R(j|a9z
|i1z47jN6P
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) s*rtm
x!S8'
ÃâÒßѧרҵ£º Rnj2Q!
C2
H3MT.Cpd
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ ARslw*SJ
AX[/S8|6
2. ÊԱȽÏÈËT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? `lr\V;o!
I#9A\.pO
´«È¾²¡Ñ§×¨Òµ£º ]kc]YO7i%R
z.#gpTXD
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦ÄÜ¿É·¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ 6VRVk7"
aNfgSo05@n
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØϵ¡£ eDG=-a4
=T;%R^@
Ïû»¯×¨Òµ£º ))u$j4V
+STT(b Mn
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ IC7n;n9
G| ^tqI
2.¼òÊöճĤÏà¹ØÁÜ°ÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌص㡣·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? yU&A[DZQ
CfA
F.H
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ wXfy,W
m&b!\"0
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 7-bU9{5
vP?"MG
1. Fas(CD95)/FasL BB=%tz`B
;<MHDmD
2. common chain of cytokine receptor DS-Kot(k(z
e$ E=n
3 . TCR/CD3 complex v-4eN1OS
liPUK #
4. negaive selection of thymocytes YgrBIul
dLG5yx\js
5. artificial active immune F71.%p7C8"
ytr~} M%
6. anti-idiotypic 7teg*M{
]`]m41+w
7. IgSF `[/B
G)4
hZ5h(CQ?"#
8. Integrin +*~?JT
3x.|g
9. chemokine \*1pFX#
jja9:$#
10. B7/CD28 -i7W|X"
315Rk!{AJ
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
\} P} H
r4D6g>)h1q
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
&-s!ko4z
@tRq(*(/:
2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣 '72ZLdi}-
dG
TAZ(1W
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 0:Ak4L6k
iVREkZ2SC
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£ TBvv(_
^+Ec}+ Q
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ r8}GiP0|
[#$z.BoEo
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ tA Pqbi$a
%koHTWT+
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© b-;+&Rb
Zii<jZ.)<
1. B7/CD28 -_4U+Cfmtl
RiIJ#:6+^I
2. Th1 subset k#w[GL|T
Kisd.~u8j
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© +i
!/J
qR--lvO
4. antibody affinity maturation BOoLs(p
BI3Q~ADV
5. AP-1 )?:V5U
O\
1ZOHyO
6. single chain variable fragment£¨ScFv£© W52AX.Nm
d@8=%x:
7. NK cell receptor ?A3pXa
%S]H
8. Zinkernagel-Doherty phenomenon e@Q<hb0<eU
0-oR
{
{
9. Ig fold .|NF8Fj
f.!)O@HzH
10. CD40/CD40L Vp.($
~B'K_#
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© .nJErC##
?H#]+SpOcv
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£ Ec y|l;
!=;^Grv>
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ TartV3;`
%K@D{)r_^
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ -n?}L#4%8
RX P 0
4
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ \Azl6`Em
%
=xR$<D
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ )q&=x
2`
+R@5e+auQ.
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ 0K <@?cI
Jtnuo]{R
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£ <03 @c s
8l-+
4~mH
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© o>m
Z$
j(F&*aH78
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?vuM'UH-
WHk/Rg%<
1.Co-stimulators (or co-stimulating molecules) rl qn39
2s_shY<=}L
2.NK-kB PsU.dv[
QijEb
3.Immunoglobulin superfamily n*(Vf'k
RbKAB8
4.antigen-presenting cell (APC) .%j(!
P/5bNK!
5.death domain R|
[mp%Q
HUiW#x%;
6.CCR and CXCR OiH
tobM
p(in.Xz
7.Lectin (or mitogen) JG @bl
1A"h!;0
8.Clusters of differentiation, CD) -fFM-gt^t
jE|Ju:}&
9.B7 family -bJht
"v@$
CR9<T
10.Cytotoxic T lymphocyte, CTL) pMnkh}Q#
o<ak&LX`9
11.IL-15 and IL-15 receptor (IL-15R) 9AK<<Mge.
":E
7#9
12.MHC restriction 6C@,&2<yK
*ci,;-*C
13.Affinity-chromatography 12BTZ
A@-nn]
14.Cyctosprin A, CsA j_Pt8{[
c'B6E1}sx
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) . #`lW7
:fz&)e9
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© aTF~rAne<
sN0S~}F+
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 9,wd,,ta
W<C
\g~\
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ rKEi1b
Lsv[@Rl
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 ?n<b:oO
T[*1*303
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Qz/o-W;
C%#=@HC
ÃâÒßѧרҵ£º COPH)Bdq.
;/?M&rX
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ !wy
Qk
Si#I^aF`%
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ZYDLl8
9a}rE
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ )N h67P3X"
eaLSq
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ)
|>o]+ V
/W&R